On the overall survival front, the primary surgery group had a 6-month benefit, but the difference was not significant — median overall survival was 54.3 months with primary surgery compared to ...

Ovarian cancer is the most deadly of gynecologic tumors. Fewer than 40% of those diagnosed with ovarian cancer are cured, and approximately 12,810 people in the U.S. die from the disease every year.

The influence of the preoperative status on the risk of postoperative complications after cytoreductive surgery for advanced-stage ovarian cancer. In Vivo. 2020;34 (2):839-844. doi:10.21873/invivo ...

Seoul National University Hospital recently announced that it successfully performed the first high-level ovarian cancer surgery in Korea using the Hugo robotic surgery system. This surgery has ...

The wife and mother underwent emergency surgery to determine the cause of her pain. "They told me it was ovarian cancer, and I never thought that would be something I would be waking up to ...

Non-BRCA Cohort To compare the pathologic findings in non- BRCA genetic carriers with BRCA carriers undergoing the risk-reduction surgery, Mubeen and colleagues evaluated clinicopathologic data on ...

References Zhao L, Cheng G, Zhou X, Xu C, Ge M, Zhou Q. Factors associated with declining cytoreductive surgery in advanced epithelial ovarian cancer: a population-based study.

I myself had no idea about any of this until 2023, when I wrote about the Ovarian Cancer Research Alliance (OCRA) making sweeping recommendations: that all women get genetically tested to know ...

Your doctor may suggest surgical removal of an ovarian cyst if it appears to be large, growing, or unusual. Here's what to expect before and after surgery.